Mixed Species Biofilms of Candida Albicans and Staphylococcus Epidermidis
Overview
Affiliations
A simple catheter disk model system was used to study the development in vitro of mixed species biofilms of Candida albicans and Staphylococcus epidermidis, two organisms commonly found in catheter-associated infections. Two strains of S. epidermidis were used: a slime-producing wild type (strain RP62A) and a slime-negative mutant (strain M7). In mixed fungal-bacterial biofilms, both staphylococcal strains showed extensive interactions with C. albicans. The susceptibility of 48-h biofilms to fluconazole, vancomycin and mixtures of the drugs was determined colorimetrically. The results indicated that the extracellular polymer produced by S. epidermidis RP62A could inhibit fluconazole penetration in mixed fungal-bacterial biofilms. Conversely, the presence of C. albicans in a biofilm appeared to protect the slime-negative staphylococcus against vancomycin. Overall, the findings suggest that fungal cells can modulate the action of antibiotics, and that bacteria can affect antifungal activity in mixed fungal-bacterial biofilms.
Antibiofilm Activity of PDMS/TiO against through Inhibited Hydrophobic Recovery.
Nguyen K, Sao L, Kyllo K, Hernandez D, Salomon S, Shah K ACS Omega. 2024; 9(41):42593-42601.
PMID: 39431067 PMC: 11483912. DOI: 10.1021/acsomega.4c07869.
The airway mycobiome and interactions with immunity in health and chronic lung disease.
Katsoulis O, Pitts O, Singanayagam A Oxf Open Immunol. 2024; 5(1):iqae009.
PMID: 39206335 PMC: 11357796. DOI: 10.1093/oxfimm/iqae009.
Engineering Microbial Consortia as Living Materials: Advances and Prospectives.
Wang S, Zhan Y, Jiang X, Lai Y ACS Synth Biol. 2024; 13(9):2653-2666.
PMID: 39174016 PMC: 11421429. DOI: 10.1021/acssynbio.4c00313.
Beyond antibiotics: CRISPR/Cas9 triumph over biofilm-associated antibiotic resistance infections.
Zuberi A, Ahmad N, Ahmad H, Saeed M, Ahmad I Front Cell Infect Microbiol. 2024; 14:1408569.
PMID: 39035353 PMC: 11257871. DOI: 10.3389/fcimb.2024.1408569.
Engineering antibacterial bioceramics: Design principles and mechanisms of action.
Nguyen N, Lu Z, Elbourne A, Vasilev K, Roohani I, Zreiqat H Mater Today Bio. 2024; 26:101069.
PMID: 38765246 PMC: 11099329. DOI: 10.1016/j.mtbio.2024.101069.